机译:MYCN扩增可预测中枢神经系统幕上原始神经外胚层肿瘤患者的预后不良
Institute of Neuropathology, University of Bonn Medical Center, Sigmund- Freud-Strasse 25, 53127 Bonn,Germany;
Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany,Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, University Medical Center Goettingen, Goettingen, Germany;
Department of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;
Institute of Neuropathology, University of Bonn Medical Center, Bonn, Germany;
Department of Pathology, University of Cologne Medical Center, Cologne, Germany;
Department of Neuroradiology, University of Wuerzburg,Wuerzburg, Germany;
Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;
Institute of Neuropathology, University of Bonn Medical Center, Bonn, Germany;
CNS-PNET; LIN28; molecular inversion probe analysis; MYCN amplification; multiplex ligation-dependent probe amplification; primitive neuroectodermal tumors of central nervous system; 2p gain;
机译:成人中枢神经系统的幕上原始神经外胚层肿瘤:12例分子和组织病理学分析。
机译:中枢神经系统的幕上原始神经外胚层肿瘤经常带有CDKN2A基因座的缺失和其他与髓母细胞瘤不同的基因组畸变。
机译:强烈的p53染色是髓母细胞瘤/中枢神经系统原始神经外胚层肿瘤预后不良的有价值的预后指标。
机译:成人中枢神经系统肿瘤的死亡率趋势,里约热内卢,1980-2010年
机译:髓母细胞瘤和幕上原始神经外胚层肿瘤候选抑癌基因的分子分析
机译:MYCN扩增可预测中枢神经系统幕上原始神经外胚层肿瘤患者的预后不良
机译:MyCN扩增预测中枢神经系统的超前原始神经分区肿瘤的患者的差异